Ketamine-Derived Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.
Heaps of ketamine, MDMA and illegal weed were seized by authorities as they busted a drug lab in Queens and arrested the ...
The Lamb of God frontman called the tech billionaire a "complete asshole." Randy Blythe Rips Elon Musk: He’s President ...
Jeni Larmour died after taking ketamine on her first night at Newcastle University back in September 2020. Sandra Larmour, ...
Musk himself has said he uses the drug to treat depression, and he's frequently posted about it on X generally over the years ...
US Weekly on MSN8d
What Celebrities and Doctors Have Said About Ketamine Use: Chrissy Teigen, Matthew Perry, MoreCelebrities like Chrissy Teigen and Matthew Perry have been open about using ketamine for their mental health – here's what ...
Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...
The study is part of psychiatry’s broad new initiative to normalize the use of hallucinogenic drugs, despite their dangerous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback